Sitaglyn is a medication specifically formulated for the management of type 2 diabetes mellitus. It contains Sitagliptin, a DPP-4 (Dipeptidyl Peptidase-4) inhibitor, which is available in a 50/1000 mg prolonged-release (PR) formulation. This medication effectively helps regulate blood sugar levels by enhancing the body's natural ability to produce insulin and by inhibiting glucose production in the liver. For optimal results, Sitaglyn is typically prescribed to be used in conjunction with a balanced diet and regular physical activity, and it may also be combined with other diabetes medications as needed. It is conveniently packaged in a strip containing 10 tablets, making it easy to manage daily dosing.